Hamilton H W, Steinbaugh B A, Stewart B H, Chan O H, Schmid H L, Schroeder R, Ryan M J, Keiser J, Taylor M D, Blankley C J
Department of Chemistry, Parke-Davis Pharmaceutical Research, Warner-Lambert Company, Ann Arbor, Michigan 48106, USA.
J Med Chem. 1995 Apr 28;38(9):1446-55. doi: 10.1021/jm00009a005.
A series of radiolabeled compounds related to renin inhibitor structures was synthesized to represent a range of physicochemical properties. These compounds were tested in assays for intestinal absorption and hepatic clearance in order to define parameters conducive to optimizing bioavailability. In general, compounds with higher lipophilicity were better absorbed from the intestine. Absorption may also be dependent on molecular charge, as compounds with ionizable functionality were less well-absorbed than neutral compounds. Neutral compounds showed some dependency on molecular weight, with smaller compounds exhibiting better absorption. While uptake into hepatic cells was rapid regardless of partition coefficient or molecular weight, rate of appearance in bile was dependent on the molecular weight of the compounds.
合成了一系列与肾素抑制剂结构相关的放射性标记化合物,以体现一系列物理化学性质。对这些化合物进行了肠道吸收和肝脏清除试验,以确定有助于优化生物利用度的参数。一般来说,亲脂性较高的化合物在肠道中的吸收更好。吸收也可能取决于分子电荷,因为具有可电离官能团的化合物比中性化合物的吸收性要差。中性化合物的吸收表现出对分子量的一定依赖性,较小的化合物吸收性更好。尽管无论分配系数或分子量如何,肝细胞对化合物的摄取都很快,但化合物在胆汁中的出现速率取决于其分子量。